Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06287008
Status:
COMPLETED
Last Update Posted:
2024-03-01
First Post:
2024-02-24
Brief Title:
ABO-Incompatible Kidney Transplants Between Robot-Assisted vs Open Surgery
Sponsor:
Asan Medical Center
Organization:
Asan Medical Center
Study Overview
Official Title:
A Comparative Study on Outcomes of ABO-Incompatible Kidney Transplants Between Robot-Assisted vs Open Surgery A Retrospective Cohort Study
Status:
COMPLETED
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
While robot-assisted kidney transplantation RAKT offers potential benefits such as minimal postoperative pain better cosmesis fewer wound infections and shorter hospital stay its efficacy in ABO-incompatible ABO-i KT compared to open KT OKT remains understudied This study aims to compare ABO-i KT outcomes between RAKT and OKT
The study utilized data from 29 ABO-i RAKT and 210 ABO-i OKT cases performed at Asan Medical Center from October 2020 to February 2023 Univariate and multivariate analyses were performed to evaluate factors associated with a composite of biopsy-proven acute rejection BPAR de novo donor-specific antibodies DSA and overall graft failure
The study utilized data from 29 ABO-i RAKT and 210 ABO-i OKT cases performed at Asan Medical Center from October 2020 to February 2023 Univariate and multivariate analyses were performed to evaluate factors associated with a composite of biopsy-proven acute rejection BPAR de novo donor-specific antibodies DSA and overall graft failure
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None